Skip to main content
Nykode Therapeutics AS (VACBF)
OTCMKTS · Delayed Price · Currency is USD
0.2749
0.00 (0.00%)
At close: Apr 23, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Novel Vaccines and Immunotherapies
136.38M
Log In
Log In
Log In
Log In
Novel Vaccines and Immunotherapies Growth
97.76%
Log In
Log In
Log In
Log In
Biopharmaceutical
-
Log In
Log In
Log In
Log In
Biopharmaceutical Growth
-
Log In
Log In
Log In
Log In
Other
-
Log In
Log In
Log In
Log In
Other Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
136.38M
Log In
Log In
Log In
Log In
United States Growth
97.76%
Log In
Log In
Log In
Log In
Norway
-
Log In
Log In
Log In
Log In
Norway Growth
-
Log In
Log In
Log In
Log In